Wellington Management Group LLP Design Therapeutics, Inc. Call Options Transaction History
Wellington Management Group LLP
- $551 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DSGN
# of Institutions
95Shares Held
30.5MCall Options Held
100Put Options Held
100-
Sr One Capital Management, LP6.53MShares$21.6 Million8.85% of portfolio
-
Logos Global Management LP San Francisco, CA5.03MShares$16.7 Million1.89% of portfolio
-
Black Rock Inc. New York, NY2.27MShares$7.53 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY1.66MShares$5.5 Million0.08% of portfolio
-
Tang Capital Management LLC San Diego, CA1.48MShares$4.9 Million0.73% of portfolio
About Design Therapeutics, Inc.
- Ticker DSGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,807,900
- Market Cap $185M
- Description
- Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...